Lawrence Dearth
About Lawrence Dearth
Lawrence Dearth is a Senior Principal Scientist at Bristol Myers Squibb with extensive experience in molecular and cellular biology.
Company
Lawrence Dearth is currently employed at Bristol Myers Squibb as a Senior Principal Scientist. He has a significant tenure at the company, having previously held the role of Principal Scientist from 2019 to 2020.
Title
Lawrence Dearth holds the title of Senior Principal Scientist at Bristol Myers Squibb. His expertise in molecular and cellular biology contributes to the development of innovative therapies, particularly in the field of autoimmune diseases.
Education and Expertise
Lawrence Dearth received his PhD in Molecular and Cellular Biology from The Ohio State University, where he studied from 1996 to 2002. He also holds a BA in Biology from the University of Hawaii at Manoa, obtained between 1992 and 1994, after attending the University of Alaska Anchorage for two years. His educational background provided a strong foundation for his research and development roles.
Professional Background
Lawrence Dearth has an extensive professional background in the field of scientific research. Before his current role at Bristol Myers Squibb, he served as a Principal Scientist at Celgene in 2019 and as a Senior Research Scientist at Celgene from 2014 to 2019. He also worked as a Research Scientist at Eli Lilly from 2007 to 2014 and began his career with a postdoctoral fellowship at UC Irvine from 2003 to 2007.
Achievements and Contributions
Lawrence Dearth has authored multiple peer-reviewed publications in molecular and cellular biology. At Bristol Myers Squibb, he has played a key role in developing innovative therapies for autoimmune diseases. Additionally, he has been involved in mentoring junior scientists and researchers. During his tenure at UC Irvine, he contributed to several successful grant applications for research funding.